FogPharma stock

FogPharma Stock

HealthTech
Founded: 2016Funding to Date: $507Mhttps://parabilismed.com

FogPharma specializes in creating cell-penetrating mini proteins (CPMPs) aimed at targeting and neutralizing cancer-causing proteins within cancer cells. These CPMPs represent a groundbreaking class of medicines capable of reaching drug targets that conventional therapies cannot address, allowing physicians to effectively treat diseases related to cancer.

Investors Include:

Alex Gorsky, Marshall Wace, Deerfield Management, Cormorant Asset Management, Horizons Ventures, WuXi AppTec, SymBiosis Capital Management, T. Rowe Price Group, HBM Healthcare Investments, RA Capital Management, The Invus Group, GV, Blue Pool Capital, Foresite Capital, Samsara BioCapital, General Catalyst, PagsGroup, Pivotal Life Sciences, Casdin Capital, Leerink Partners, Fidelity Management & Research, HBM Partners, Rock Springs Capital, venBio, 6 Dimensions Capital.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Management Team

Kristen StantsChief People Officer
John McGee Ph.DScientific Co-Founder, Vice President of De Novo Discovery & Head of De Novo Discovery
Mathai Mammen Ph.DChief Executive Officer, President & Chairman
Michael Hale Ph.DVice President, Chemistry
David Lane Ph.DCo-Founder
Rohin Mhatre Ph.DChief Technical Operations Officer & Executive Vice President
Keith Orford Ph.DChief Medical Officer & Executive Vice President of Clinical and Translational Science
Thomas KotarakosExecutive Vice President Of Finance
Jonathan Hurov Ph.DExecutive Vice President, Discovery Biology
Gregory MillerChief Business Officer
Brandon Allgood Ph.DChief Data Officer

Board Members

Alexis BorisyBoard Member
Jeffrey LeerinkBoard Member
Krishna Yeshwant MDBoard Member
Lianyong Chen Ph.DBoard Member
Corey Goodman Ph.DBoard Member
Richard Klausner MDBoard Member

FogPharma’s stock FAQs

Other HealthTech Companies in Collective's mid-stage Target Portfolio.

A2 Bio stock
Aardvark Therapeutics stock
AcuityMD stock
Alamar Biosciences stock
Alterome Therapeutics stock
Arbor Biotechnologies stock
Attralus stock
Be Biopharma stock
Bluejay Therapeutics stock
Brightside Health stock
Capstan Therapeutics stock
Carrum Health stock
Casana stock
Cellanome stock
Centivo stock
Chroma Medicine stock
Conformal stock
Convergent Therapeutics stock
Covera Health stock
Detect stock
Dewpoint Therapeutics stock
Dispatch Biotherapeutics stock
Egenesis stock
Elektrofi stock
Engrail Therapeutics stock
Equip stock
Firefly Health stock
Flare Therapeutics stock
Florence stock
Foresight Mental Health stock
Frontier Medicines stock
Genesis Therapeutics stock
Graviton BioScience stock
Hexagon Bio stock
Iambic Therapeutics stock
IDRx stock
Inceptive stock
Infinitus Systems stock
KSQ stock
Levels stock
LifeMine stock
LightForce stock
Loyal stock
Luna Physical Therapy stock
Lycia Therapeutics stock
Marea stock
Medallion stock
Nalu Medical stock
Neuron23 stock
NextPoint stock
OrsoBio stock
Ossium Health stock
Ostro stock
Overjet stock
Pager stock
Paradigm stock
Paradromics stock
Pathalys Pharma stock
Pelago stock
Pomelo Care stock
Rad AI stock
ReCode Therapeutics stock
Regard stock
Rivus Pharmaceuticals stock
Route 92 stock
SalioGen Therapeutics stock
Santa Ana Bio stock
Seismic Therapeutic stock
Sionna stock
SmarterDx stock
SmithRx stock
Strand Therapeutics stock
Suki stock
Syllable stock
Synchron stock
Synthekine stock
Third Arc Bio stock
Tome Biosciences stock
Tomorrow Health stock
Triveni Bio stock
Two Chairs stock
Unlearn stock
Vanqua Bio stock
Verse Medical stock
Viome Life Sciences stock
Vizgen stock